Brief: FDA Directs Takeda To Add Boxed Warning To Adzynma Drug Label
23/09/2026 23:13
BRIEF-FDA Directs Takeda To Add Boxed Warning To Adzynma Drug Label Sept 23 (Reuters) - FDA:
FDA: DIRECTED TAKEDA PHARMACEUTICALS TO ADD BOXED WARNING, ON DRUG LABEL, TO ADZYNMA'S PRESCRIBING INFORMATION
Further company coverage: 4502.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Takeda Pharmaceutical
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom (updated)